Venture Capital Investors

Section 32

VC investing group Section 32 provides capital to innovative tech companies.

Venture Investor Overview

Venture Investor
Section 32
Status
Active
Investor Type
Venture Capital
Activity Level
85 transactions
Funds Raised
At least $1.1 billion
Industry Focus
Artificial Intelligence
Biopharmaceutical
Blockchain
Communications
Enterprise IT
FinTech
Healthcare IT
Healthcare Services
Internet & IoT
Medical Devices & Instruments
Networking
Security
Software

Contact Information

Contact
Bill Maris
Title
Founder
Mailing Address
2033 San Elijo Ave. 565
Cardiff-By-The-Sea, CA 92007
USA
Phone
858-633-3232
Website
www.section32.com
Email Address
[email protected]

Background Information

Overview
Section 32 is the venture capital firm founded by ex Google Venture Capital founder Bill Maris.
Profile
Section 32 LinkedIn Company Profile
Social Media
Section 32 Company Twitter Account
Company News
Section 32 News
Facebook
Section 32 on Facebook
YouTube
Section 32 on YouTube
Last Transaction
3/26/2024

Transaction History

Our records indicate that Section 32 invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
Brightside Health
3/26/2024
$33,000,000
Freenome
2/15/2024
$254,000,000
Pomelo.la
1/17/2024
$40,000,000
Endor Labs
8/3/2023
$70,000,000
Octave Bioscience
7/26/2023
$30,000,000
AltPep
6/26/2023
$53,000,000
Function Oncology
4/12/2023
$28,000,000
Faro Health
2/9/2023
$20,000,000
Forward Networks
1/24/2023
$50,000,000
MedCrypt
11/1/2022
$25,000,000
Stairwell
10/11/2022
$45,000,000
Nested Therapeutics
10/6/2022
$90,000,000
Inworld AI
8/24/2022
$50,000,000
Spectral Finance
8/24/2022
$23,000,000
BigHat Biosciences
7/20/2022
$75,000,000
Phaidra
7/18/2022
$25,000,000
Manifold Bio
7/14/2022
$40,000,000
Primer
6/2/2022
$40,000,000
Legacy
5/12/2022
$25,000,000
Moma Therapeutics
5/10/2022
$150,000,000
Aspen Neuroscience
5/9/2022
$147,500,000
Syllable
4/25/2022
$40,000,000
Satellite Bio
4/20/2022
$110,000,000
Parallel Finance
4/5/2022
$5,000,000
Celsius Therapeutics
3/24/2022
Unknown
Nucleai
3/24/2022
$33,000,000
SandboxAQ
3/22/2022
Unknown
Cohere
3/7/2022
$125,000,000
ONI
1/28/2022
$75,000,000
Verge Genomics
12/21/2021
$98,000,000
Nodexus
12/21/2021
$30,000,000
Dialpad
12/17/2021
$170,000,000
Exai Bio
12/10/2021
$67,500,000
Mekonos
11/11/2021
$25,000,000
Arbor Biotechnologies
11/10/2021
$215,000,000
Parthenon Therapeutics
11/6/2021
$65,000,000
Culture Biosciences
10/18/2021
$80,000,000
Gretel
10/8/2021
$50,000,000
Rome Therapeutics
9/15/2021
$77,000,000
ImmuneID
6/24/2021
$50,000,000
Phaidra
5/25/2021
$4,000,000
TwinStrand Biosciences
5/7/2021
$50,000,000
Current Health
4/23/2021
$43,000,000
C2i Genomics
4/17/2021
$100,000,000
Legacy
4/15/2021
$10,000,000
Meatable
3/24/2021
$47,000,000
Miroculus
2/26/2021
$45,000,000
Octave Bioscience
12/21/2020
$32,000,000
Octave Bioscience
12/18/2020
$32,000,000
WithMe Health
11/25/2020
$20,000,000
Vineti
10/14/2020
$68,000,000
Neocis
10/9/2020
$72,000,000
Dialpad
10/7/2020
$100,000,000
Freenome
8/31/2020
$270,000,000
Thrive Earlier Detection
7/30/2020
$257,000,000
Sema4
7/30/2020
$121,000,000
Glympse Bio
7/17/2020
$46,700,000
Evidation Health
7/2/2020
$45,000,000
Autobahn Therapeutics
6/10/2020
$76,000,000
Aspen Neuroscience
4/2/2020
$70,000,000
Vineti
2/6/2020
$35,000,000
XOKind
12/13/2019
$1,670,000
Aspen Neuroscience
12/13/2019
$6,500,000
Freenome
7/25/2019
$160,000,000
Cradle Genomics
7/17/2019
$17,100,000
Thrive Earlier Detection
5/31/2019
$110,000,000
MedCrypt
5/8/2019
$5,300,000
Embark Veterinary
4/12/2019
$10,000,000
Culture Biosciences
2/13/2019
$5,500,000
Ciitizen
1/17/2019
$17,000,000
Primer
11/22/2018
$40,000,000
Fulcrum Therapeutics
9/6/2018
$80,000,000
Alector
7/26/2018
$133,000,000
MetroMile
7/25/2018
$90,000,000
Dialpad
7/18/2018
$50,000,000
Octave Bioscience
7/13/2018
$14,000,000
Cue Health
7/11/2018
$45,000,000
Vineti
4/17/2018
$33,500,000
Lime
2/16/2018
$70,000,000
Relay Therapeutics
12/15/2017
$63,000,000
Lime
10/17/2017
$50,000,000
Kobalt
10/13/2017
$14,000,000
Coinbase
8/11/2017
$100,000,000
Embark Veterinary
7/19/2017
$4,500,000
BloomAPI
7/14/2017
$2,400,000

 

Investor Contacts

Title
Name
Email & Social
Founder
Bill Maris
  Bill Maris LinkedIn Profile  Bill Maris Twitter Account  Bill Maris News  Bill Maris on Facebook

 

Funds

Our database includes the following fund closing(s) for Section 32. If we are missing funds, please contact us.

Fund Description
Vintage Date
Fund Amount
Fund 4
11/4/2021
$740,000,000
Section 32 Fund 2
2/25/2019
$199,350,000
Fund I
5/16/2017
$150,000,000

 

Portfolio Companies

Section 32 has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
Alector
AltPep
Arbor Biotechnologies
Aspen Neuroscience
Autobahn Therapeutics
BigHat Biosciences
BloomAPI
Brightside Health
C2i Genomics
Celsius Therapeutics
Ciitizen
Cohere
Coinbase
Cradle Genomics
Cue Health
Culture Biosciences
Current Health
Dialpad
Embark Veterinary
Endor Labs
Evidation Health
Exai Bio
Faro Health
Forward Networks
Freenome
Fulcrum Therapeutics
Function Oncology
Glympse Bio
Gretel
ImmuneID
Inworld AI
Kobalt
Legacy
Lime
Manifold Bio
Meatable
MedCrypt
Mekonos
MetroMile
Miroculus
Moma Therapeutics
Neocis
Nested Therapeutics
Nodexus
Nucleai
Octave Bioscience
ONI
Parallel Finance
Parthenon Therapeutics
Phaidra
Pomelo.la
Primer
Relay Therapeutics
Rome Therapeutics
SandboxAQ
Satellite Bio
Sema4
Spectral Finance
Stairwell
Syllable
Thrive Earlier Detection
TwinStrand Biosciences
Verge Genomics
Vineti
WithMe Health
XOKind

 

 

 

 

Browse more venture capital investors:

SecretLab LLC | Sectoral Asset Management

 

Share this article

 

About Our Venture Capital Investor Database

This VC firm profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.